Viruses (Apr 2024)

Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin

  • Valeria Manca,
  • Annalisa Chianese,
  • Vanessa Palmas,
  • Federica Etzi,
  • Carla Zannella,
  • Davide Moi,
  • Francesco Secci,
  • Gabriele Serreli,
  • Giorgia Sarais,
  • Maria Vittoria Morone,
  • Massimiliano Galdiero,
  • Valentina Onnis,
  • Aldo Manzin,
  • Giuseppina Sanna

DOI
https://doi.org/10.3390/v16050665
Journal volume & issue
Vol. 16, no. 5
p. 665

Abstract

Read online

Severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2) has infected more than 762 million people to date and has caused approximately 7 million deaths all around the world, involving more than 187 countries. Although currently available vaccines show high efficacy in preventing severe respiratory complications in infected patients, the high number of mutations in the S proteins of the current variants is responsible for the high level of immune evasion and transmissibility of the virus and the reduced effectiveness of acquired immunity. In this scenario, the development of safe and effective drugs of synthetic or natural origin to suppress viral replication and treat acute forms of COVID-19 remains a valid therapeutic challenge. Given the successful history of flavonoids-based drug discovery, we developed esters of substituted cinnamic acids with quercetin to evaluate their in vitro activity against a broad spectrum of Coronaviruses. Interestingly, two derivatives, the 3,4-methylenedioxy 6 and the ester of acid 7, have proved to be effective in reducing OC43-induced cytopathogenicity, showing interesting EC50s profiles. The ester of synaptic acid 7 in particular, which is not endowed with relevant cytotoxicity under any of the tested conditions, turned out to be active against OC43 and SARS-CoV-2, showing a promising EC50. Therefore, said compound was selected as the lead object of further analysis. When tested in a yield reduction, assay 7 produced a significant dose-dependent reduction in viral titer. However, the compound was not virucidal, as exposure to high concentrations of it did not affect viral infectivity, nor did it affect hCoV-OC43 penetration into pre-treated host cells. Additional studies on the action mechanism have suggested that our derivative may inhibit viral endocytosis by reducing viral attachment to host cells.

Keywords